company background image
SYK logo

Stryker Informe acción NYSE:SYK

Último precio

US$387.11

Capitalización de mercado

US$144.4b

7D

4.7%

1Y

36.8%

Actualizada

12 Nov, 2024

Datos

Finanzas de la empresa +

Stryker Corporation

Informe acción NYSE:SYK

Capitalización de mercado: US$144.4b

Resumen de acción SYK

Stryker Corporation opera como empresa de tecnología médica.

Acerca de la empresa

Análisis fundamental de SYK
Puntuación del snowflake
Valoración1/6
Crecimiento futuro2/6
Rendimiento pasado5/6
Salud financiera3/6
Dividendos4/6

Recompensas

Se prevé un crecimiento anual de los beneficios de 11.39%

Los beneficios aumentaron un 38.9% el pasado año

Análisis de riesgos

Venta significativa por parte de personas con información privilegiada en los últimos 3 meses

Tiene un alto nivel de endeudamiento


Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WA
WarrenAI
Based on Analyst Price Targets

Continued MedSurg And Neurotechnology Innovation Drives Exciting Growth And Revenue Momentum

Key Takeaways Ongoing international expansion and strategic acquisitions are The analysts have a consensus price target of $390.28 for Stryker based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $420.0, and the most bearish reporting a price target of just $276.0. In order for you to agree with the analyst's consensus, you'd need to believe that by 2027, revenues will be $27.8 billion, earnings will come to $4.9 billion, and it would be trading on a PE ratio of 36.5x, assuming you use a discount rate of 6.5%.
View narrative
US$390.28
FV
0.8% undervalued intrinsic discount
8.14%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
7 days ago author updated this narrative
TO
Tokyo
Community Contributor

Investing in Stryker (SYK) should be an easy ride

Investing in Stryker (SYK) should be an easy ride Key “Take aways”: - Solid balance sheet - Earnings recovered, with positive outlook. - SYK is fair priced.
View narrative
US$323.52
FV
19.7% overvalued intrinsic discount
6.00%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
4 months ago author updated this narrative

Competidores de Stryker Corporation

Boston Scientific

NYSE:BSX

US$130.4b

Intuitive Surgical

NasdaqGS:ISRG

US$190.8b

Medtronic

NYSE:MDT

US$113.2b

Abbott Laboratories

NYSE:ABT

US$202.6b

Historial de precios y rendimiento

Resumen de todos los máximos históricos, cambios y caídas de precios de Stryker
Precios históricos de las acciones
Precio actual de la acciónUS$387.11
Máximo en las últimas 52 semanasUS$388.12
Mínimo de 52 semanasUS$282.35
Beta0.92
1Cambio en 1 mes8.86%
Variación en 3 meses16.36%
Cambio de 1 año36.77%
3Variación en 3 años47.58%
Variación en 5 años86.90%
Variación desde la OPV71,366.42%

Noticias y actualizaciones recientes

Stryker's Growth Via Continuous Acquisitions Led To Declining ROIC

Oct 16

Recent updates

Stryker's Growth Via Continuous Acquisitions Led To Declining ROIC

Oct 16

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Oct 10
We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Sep 29
A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Sep 18
Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt

Sep 01
We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt

Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Aug 21
Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Aug 10
Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker: Wait For A Better Entry Point Post-Q2 Results

Aug 06

Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?

Jul 11
Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Jun 30
A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

Jun 19
Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

The Returns At Stryker (NYSE:SYK) Aren't Growing

Jun 16
The Returns At Stryker (NYSE:SYK) Aren't Growing

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Jun 05
Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker: Margin Gains Should Drive Upside

May 31

Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

May 25
Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings

May 14
Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 02
Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Apr 29
We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Stryker: A Great Company At An Expensive Price

Apr 05

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Mar 26
Stryker's (NYSE:SYK) Dividend Will Be $0.80

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Mar 25
Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

Mar 14
Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Feb 21
At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Feb 10
Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Feb 02

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 02
Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

Jan 24
Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Jan 02
Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Stryker: Mako Shoulder And Spine Launches Are On The Way

Dec 31

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 22
Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 08
Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Why Stryker Is An Awesome Healthcare Compounder

Nov 30

Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Nov 10
Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Oct 19
Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Stryker: Don't Buy This Dividend Champion (Yet)

Oct 13

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Oct 08
Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Is Stryker (NYSE:SYK) A Risky Investment?

Sep 26
Is Stryker (NYSE:SYK) A Risky Investment?

Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology

Aug 22

Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Jul 18
Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Rentabilidad de los accionistas

SYKUS Medical EquipmentMercado US
7D4.7%1.2%3.9%
1Y36.8%27.0%33.2%

Rentabilidad vs. Industria: SYK superó a la industria US Medical Equipment, que obtuvo un rendimiento del 27% el año pasado.

Rentabilidad vs. Mercado: SYK superó al mercado US, que obtuvo un rendimiento del 33.2% el año pasado.

Volatilidad de los precios

Is SYK's price volatile compared to industry and market?
SYK volatility
SYK Average Weekly Movement2.3%
Medical Equipment Industry Average Movement8.0%
Market Average Movement6.2%
10% most volatile stocks in US Market15.4%
10% least volatile stocks in US Market3.0%

Precio estable de las acciones: SYK no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de SYK (2%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
194152,000Kevin Lobowww.stryker.com

Stryker Corporation es una empresa de tecnología médica. La empresa opera a través de dos segmentos, MedSurg y Neurotecnología, y Ortopedia y Columna Vertebral. El segmento de Ortopedia y Columna vertebral suministra implantes para su uso en sustituciones articulares totales, como cadera, rodilla y hombro, y cirugías de traumatismos y extremidades.

Resumen de fundamentos de Stryker Corporation

¿Cómo se comparan los beneficios e ingresos de Stryker con su capitalización de mercado?
Estadísticas fundamentales de SYK
Capitalización bursátilUS$144.43b
Beneficios(TTM)US$3.59b
Ingresos (TTM)US$21.97b

41.1x

Ratio precio-beneficio (PE)

6.7x

Ratio precio-ventas (PS)

¿Está SYK sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de SYK
IngresosUS$21.97b
Coste de los ingresosUS$7.92b
Beneficio brutoUS$14.06b
Otros gastosUS$10.47b
BeneficiosUS$3.59b

Últimos beneficios comunicados

Sep 30, 2024

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)9.42
Margen bruto63.97%
Margen de beneficio neto16.34%
Ratio deuda/patrimonio76.8%

¿Cómo se ha desempeñado SYK a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

0.8%

Rentabilidad actual por dividendo

34%

Ratio de pagos